Growth Metrics

BioNexus Gene Lab (BGLC) Equity Income (2024 - 2025)

BioNexus Gene Lab's Equity Income history spans 2 years, with the latest figure at -$28256.0 for Q4 2025.

  • Quarterly results put Equity Income at -$28256.0 for Q4 2025, up 83.72% from a year ago — trailing twelve months through Sep 2025 was -$145351.0 (changed N/A YoY), and the annual figure for FY2024 was $69476.0, down 77.34%.
  • Equity Income for Q4 2025 was -$28256.0 at BioNexus Gene Lab, down from $23742.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $88532.0 in Q2 2024 to a low of -$173607.0 in Q4 2024.